Study of Vorinostat in Combination With Gemcitabine and Docetaxel in Advanced Sarcoma
Clinical trial NCT01879085 · COMPLETED
Trial details
- NCT number
- NCT01879085
- Sponsor
- Melissa Burgess, MD
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-24
- Primary completion
- 2021-04-15
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.